More importantly, they are not making a profit due to the DIR fees which have increased dramatically over the last two years. If they had stayed constant, or close to it, we would have been profitable quarters ago.
Thankfully, their growth areas, 340B and ClearMetrics, don't involve those fees.
$RXMD